Friday 30 October 2020 ,
Latest News
25 September, 2020 10:29:51 AM / LAST MODIFIED: 25 September, 2020 07:20:17 PM

Print

Coronavirus vaccine to be ready by early 2021: Chinese company

UNB/AP, Beijing
Coronavirus vaccine to be ready by early 2021: Chinese company

A Chinese pharmaceutical company said Thursday the coronavirus vaccine should be ready by early next year for distribution worldwide, including the United States.

Yin Weidong, the CEO of SinoVac, vowed to apply to the US Food and Drug Administration to sell CoronaVac in the US if it passes its third and final round of testing in humans.

Yin said he personally has been given the experimental vaccine.

“At the very beginning, our strategy was designed for China and for Wuhan. Soon after that in June and July we adjusted our strategy, that is to face the world,” Yin said, referring to the Chinese city were the virus first emerged, reports AP.

“Our goal is to provide the vaccine to the world including the US, EU and others,” Yin said.

Stringent regulations in the US, European Union, Japan and Australia have historically blocked the sale of Chinese vaccines.

But Yin said that could change.

SinoVac is developing one of China’s top four vaccine candidates along with state-owned SinoPharm, which has two in development, and military-affiliated private firm CanSino.

More than 24,000 people are currently participating in clinical trials of CoronaVac in Brazil, Turkey, and Indonesia, with additional trials scheduled for Bangladesh and possibly Chile, Yin said.

SinoVac chose those countries because they all had serious outbreaks, large populations and limited research and development capacity, he said.

The company projects it will be able to produce a few hundred million doses of the vaccine by February or March of next year.

SinoVac is also starting to test small doses of CoronaVac on children in the three countries because of the high rate of infection among young people there. Yin said the company would prioritise distribution of the vaccine to countries hosting human trials of CoronaVac.

While the vaccine has not yet passed the phase 3 clinical trials, a globally accepted standard, SinoVac has already injected thousands of people in China under an emergency use provision.

Yin said he was one of the first to receive the experimental vaccine months ago along with researchers after phase one and two of human trials showed no serious adverse effects. He said that self-injecting showed his support for CoronaVac.

“This is kind of a tradition of our company,” Yin said, adding that he had done the same with a hepatitis vaccine under development.

 

SI

 

Comments

Poll
Today's Question »
State minister for power Nasrul Hamid yesterday said everyone to have access to electricity by June. Do you think the feat achievable by the timeframe?
 Yes
 No
 No Comment
Yes 47.3%
No 48.7%
No Comment 4.1%
Video
More World News Stories

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting